Graded thin-layer systems made of metal-ceramic composites for coating cardiovascular implants

DE502021005573D1Active Publication Date: 2024-11-14ANMELDERANGABEN UNKLAR UNVOLLSTANDIG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE502021005573
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-04-29
Filing Date
2021-04-28
Publication Date
2024-11-14
Estimated Expiration
2041-04-28

AI Technical Summary

Technical Problem

Current metallic cardiovascular implants, such as stents, face issues with stent thrombosis and restenosis due to poor hemocompatibility, leading to high mortality rates and recurring vascular occlusions, despite drug-eluting stents and existing coatings like zirconium oxide or nitride, which struggle with adhesion and are costly to produce.

Method used

A graded metal-ceramic composite coating is applied using a hydrometallurgical process involving an aqueous dispersion of metal salts and ceramic particles, where the metal matrix is co-deposited with ceramic particles to create a thin film on cardiovascular implants, ensuring better adhesion and hemocompatibility by varying the metal and ceramic proportions through pulsed current and duty cycle control.

Benefits of technology

The graded metal-ceramic composite coating enhances hemocompatibility and extends the service life of cardiovascular implants by ensuring excellent adhesion and reduced thrombosis risk, improving patient outcomes and reducing mortality associated with stent implantation.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The invention relates to a method for producing a graded metal-ceramic composite coating on a metallic cardiovascular implant and correspondingly produced cardiovascular implants, in particular stents.

[0002] Stents are generally tubular devices made of metal or metal alloys such as chromium-nickel alloy or cobalt-based alloy (316L, L605) that are used to treat atherosclerotic stenosis in blood vessels to keep a section of the vessel patent. Stents are typically hollow structures with lattice-like, open wall surfaces that can be expanded within the vessel. During stent implantation, injuries to the vessel walls are inevitable. These injuries can activate the coagulation system, leading to dangerous stent thrombosis with acute occlusion of the vessel, which is associated with a mortality rate of approximately 45%. The drug-eluting stents (DES) currently in use are coated with specific medications such as biolimus, zotarolimus, or everolimus, which can inhibit neointimal hyperplasia—i.e., excessive cell formation within the stent—that leads to restenosis.The drugs can be immobilized directly on the surface of the stent, infiltrated into the porous structures on the surface, or integrated into a resorbable plastic coating. However, depending on the lesion type, restenosis occurs at a rate of up to 20% after six months. Therefore, further improvements in the hemocompatibility of the materials used are necessary to further reduce the rates of stent thrombosis and restenosis.

[0003] Various stent coatings are known in the art. For example, US Pat. No. 5,496,359 A describes the coating of medical devices such as balloon stents with zirconium oxide or zirconium nitride. US Pat. No. 5,649,951 A also describes stents coated with zirconium oxide or zirconium nitride. DE 59609528 D1 describes a method for producing a graded coating on a metal implant using an electrochemical process. The implant is made of titanium or titanium alloys and is intended for use as a dental, jaw, or joint implant. DE 69627143 T2 describes a metal stent with a blood- and biocompatible protective layer applied thereto, to which a metal coating is further applied to increase the radiopacity of the stent.However, directly coating metallic implants with ceramic leads to poor adhesion and is unsuitable for medical applications. To improve the adhesion between the layers, DE 69627143 T2 proposes silanization, acid treatment, or sandblasting. DE 10 2020 020329 A1 describes the galvanic coating of a stent with magnesium.

[0004] DE 195 38 046 A1 describes a layer system consisting of a metal layer, a ceramic layer, and a graded mixed layer of metal and ceramic between them. As an application example, only C-Al graded layers on a silicon wafer are described, and the layer deposition is carried out using plasma coating processes. However, such processes are unsuitable for the production of medical products and are associated with excessive costs.

[0005] US 2007 / 264303 A1 generally relates to an implantable medical device for delivering a therapeutic agent to a patient's body tissue and to a method for manufacturing such a medical device. In particular, an implantable medical device, such as an intravascular stent, with a coating comprising an inorganic or ceramic oxide, such as titanium oxide, and a therapeutic agent is described.

[0006] The object of the present invention was to provide a method for applying a graded thin layer of a metal-ceramic composite material to a metallic implant that overcomes at least one of the aforementioned disadvantages of the prior art.

[0007] This object is achieved by a method for producing a graded metal-ceramic composite coating on a metallic cardiovascular implant, wherein the composite coating is applied by a hydrometallurgical process from an aqueous dispersion comprising a dissolved metal salt or a dissolved metal compound and dispersed ceramic particles. This object is further achieved by a metallic cardiovascular implant according to claim 7.

[0008] The process enables a uniform, thin, and homogeneous coating of the complex surface of an implant such as a stent with a metal-ceramic composite material. The co-deposition of a metal matrix with ceramic particles enables a graded metal-ceramic composite coating in the form of a thin film on cardiovascular implants. The term "cardiovascular implants" refers to implants with blood contact, such as stents or heart valves. In this case, the gradation of the layer ensures better adaptation and adhesion to the metallic substrate. Electroplating co-deposition of a graded metal-ceramic composite coating directly onto the implant allows for excellent utilization of the positive properties of the ceramic.The graded metal-ceramic composite coating thus provides improved hemocompatibility and increased durability of the coated implants, which can lead to a reduction in mortality.

[0009] The term "hydrometallurgical processes" collectively includes metallurgical processes for the deposition of metals, in particular electrochemical processes (electrophoresis) and galvanization.

[0010] Here, the metallic cardiovascular implant forms the substrate electrode, and the aqueous dispersion forms the electrolyte, into which a counter electrode is inserted. By applying a pulsed current and varying the duty cycle, variable proportions of metal and ceramic and gradations in the deposited coating can be achieved. The term "gradation" of a mixed layer refers to the material proportion of one component continuously decreasing in one direction, for example, the growth direction of the layer, while the material proportion of the other component increases in the opposite direction. A continuous decrease means that sudden or step-like changes in concentration are avoided. In this case, the metal is deposited first, so that the part of the thin film in direct contact with the implant is formed almost entirely, or almost 100%, from metal.This enables the metal-ceramic composite to adhere to the metallic implant. During deposition, the proportion of deposited metal decreases in the direction of the layer's growth, i.e., from the inside out, while the proportion of deposited ceramic particles increases in the opposite direction. The outer layer of the deposited metal-ceramic composite, which comes into contact with blood during use, is formed almost entirely, or almost 100%, from the ceramic. This makes it hemocompatible.

[0011] In preferred embodiments, the metal of the metal salt is selected from the group comprising nickel, cobalt, chromium, molybdenum, iron, and combinations thereof. A preferred combination of metals are alloys such as cobalt-based alloys with proportions of nickel, chromium, and tungsten, for example, L605, or cobalt-chromium alloys, in particular Ni-Co-Cr-Mo alloys such as F562, and comparable alloys. The metal used can correspond to the metal or metal alloys from which the metallic cardiovascular implant is formed. The term "metallic" cardiovascular implant includes metal alloys such as steels.

[0012] Organic and inorganic salts and compounds of these metals that are soluble in aqueous solution can be used. Preferred metal salts are salts of the metals that are readily soluble in aqueous solution, such as chlorides or sulfates, which can be in hydrate form. In embodiments, the metal salt is selected from the group comprising nickel(II) sulfate, nickel(II) chloride, cobalt(II) sulfate, cobalt(II) chloride, chromium(III) chloride, chromium(III) sulfate, sodium molybdate, iron(II) chloride hydrate, iron(II) sulfate hydrates, in particular iron(II) sulfate monohydrate, and / or combinations thereof. The metal salt is preferably selected from the group comprising nickel(II) sulfate, cobalt(II) sulfate and / or chromium(III) chloride. Furthermore, metal compounds such as chromic acid (H2CrO4) can be used or can form in dilute aqueous solution.

[0013] The concentration of the metal salts in the aqueous dispersion or the electrolyte can vary. In embodiments, the concentration of the metal salt(s) or the concentration of the metal compound in the aqueous dispersion is in the range from ≥ 10 g / L to ≤ 500 g / L, in the range from ≥ 10 g / L to ≤ 400 g / L, preferably in the range from ≥ 30 g / L to ≤ 300 g / L, more preferably in the range from ≥ 60 g / L to ≤ 300 g / L. To produce a matrix of nickel and cobalt, nickel and cobalt salts are preferably used in the same concentration in the electrolyte, for example in a concentration of 60 g / L each, so that the total concentration of the salts is preferably in the range from ≥ 100 g / L to ≤ 200 g / L. The concentration of chromium salts is preferably in the range of ≥ 100 g / L to ≤ 300 g / L. The concentration of chromium salt can be three to four times higher than the concentration of nickel and / or cobalt salts.

[0014] The pH of the dispersion or electrolyte is preferably in the slightly acidic to neutral range. In embodiments, the aqueous dispersion or electrolyte has a pH in the range of ≥ 2 to ≤ 7, preferably in the range of ≥ 2 to ≤ 5. In preferred embodiments, the aqueous dispersion or electrolyte has a pH in the range of ≥ 1 to ≤ 6, preferably in the range of ≥ 1 to ≤ 3. It has been found that a pH in these ranges has a positive effect on the deposition behavior. The pH can be adjusted, for example, with boric acid, citric acid, and / or ammonia.

[0015] In embodiments, the ceramic is selected from the group comprising aluminum oxide, zirconium oxide, silicon carbide, and / or silicon nitride. These ceramic materials are characterized by their highly bioinert properties. In particular, oxide ceramics such as aluminum oxide (Al 2 O 3 ) exhibit high hemocompatibility and blood compatibility. Non-oxide ceramics such as silicon carbide (SiC) in its various polymorphic modifications also exhibit excellent blood compatibility. In embodiments, the concentration of the ceramic particles in the aqueous dispersion is in the range of ≥ 10 g / L to ≤ 150 g / L, preferably in the range of ≥ 30 g / L to ≤ 100 g / L. At higher concentrations, the viscosity of the dispersion may increase, slowing down deposition. In embodiments, the concentration of Al 2 O 3 particles in the aqueous dispersion is in the range of ≥ 10 g / L to ≤ 150 g / L, preferably in the range of ≥ 30 g / L to ≤ 100 g / L.It was found that composite layers deposited from dispersions with a concentration of 30 g / L of Al 2 O 3 particles showed lower cytotoxicity.

[0016] In embodiments, the ceramic particles have an average particle size in the range of ≥ 30 nm to ≤ 100 nm, preferably in the range of ≥ 40 nm to ≤ 100 nm, preferably in the range of ≥ 50 nm to ≤ 70 nm. Particles in these size ranges can form stable colloidal systems. Larger particles, on the other hand, sediment more quickly, which is undesirable for colloidal systems and co-deposition.

[0017] In preferred embodiments for depositing a metal-ceramic composite coating, cobalt salt, nickel salt, and aluminum oxide particles are deposited to form a CoNi-Al 2 O 3 composite coating. In further preferred embodiments for depositing a metal-ceramic composite coating, cobalt salt, nickel salt, chromium salt, and aluminum oxide particles are deposited to form a CoNiCr-Al 2 O 3 composite coating, or cobalt salt, nickel salt, chromium salt, molybdenum salt, and aluminum oxide particles are deposited to form a CoNiCrMo-Al 2 O 3 composite coating.

[0018] In an electrolysis arrangement in which the aqueous dispersion forms the electrolyte, the metallic cardiovascular implant serves as the substrate electrode and can be combined with a suitable counter electrode and reference electrode. The gradation of the proportions of metal and ceramic in the deposited composite coating can be achieved by a pulsed current and a variation of the duty cycle. Varying the duty cycle is a fundamentally known digital method for controlling electrical voltage and power. The duty cycle specifies the ratio of the pulse duration (Torr) to the total period duration for a periodic sequence of pulses and has a value range between 0 and 100%. The period duration is made up of the on times (Torr) and the off times (T OFF ) and could occur periodically over a defined period of time, for example, from 5 to 10 minutes.Frequencies between 10 and 1000 Hz are used, for example, and a preferred current strength is between 0.1 and 0.3 A. During the pulse duration (Torr), metals are preferentially deposited on the counter electrode. In contrast, during the off times (T OFF ), more dispersed ceramic particles are incorporated into the coating. Since the proportion of incorporated particles is intended to increase across the coating from the substrate to the surface, a duty cycle of 90% is used at the beginning, this is then reduced to 50% and finally amounts to 10% in the last deposition phase. The total duration of the electrolysis can vary between 15 and 60 minutes, preferably between 15 and 30 minutes. The temperature can vary between 25 °C and 60 °C, preferably between 30-40 °C.

[0019] Using the described method, a graded metal-ceramic composite coating can be deposited from the aqueous dispersion onto a metallic cardiovascular implant. The graded metal-ceramic composite coating, or thin film, is deposited directly onto the metal and preferably encloses all parts of the stent that are inserted into the body as a cardiovascular prosthesis and remain there. A thin film is defined as a layer with a thickness in the micrometer or nanometer range. The graded metal-ceramic composite coating prevents blood particles from adhering to the coating as they would to a metallic stent. This improves the hemocompatibility of the implant and increases the service life of the coated implants.

[0020] The invention further relates to a metallic cardiovascular implant, wherein the implant comprises a graded metal-ceramic composite coating of a metal selected from the group comprising nickel, cobalt, chromium, molybdenum, iron, and combinations thereof, and particles of a ceramic selected from the group comprising aluminum oxide, zirconium oxide, silicon carbide, and / or silicon nitride, produced by the method according to the invention. For further description, reference is made to the above statements regarding the method.

[0021] The graded metal-ceramic composite coating is specifically designed as a thin film. In the graded metal-ceramic composite coating, the metal content decreases continuously from the surface of the metallic implant toward the outside, while the proportion of ceramic particles increases in the opposite direction. The portion of the thin film in direct contact with the implant is composed almost entirely, or almost 100%, of metal. This enables the metal-ceramic composite to adhere to the metallic implant. The outer layer of the metal-ceramic composite, which comes into contact with blood during use, is composed almost entirely, or almost 100%, of ceramic. This makes the surface of the coated cardiovascular implant hemocompatible.

[0022] The metallic cardiovascular implant is preferably a stent or a heart valve. In preferred embodiments, the metallic cardiovascular implant is a stent.

[0023] In other words, a composite coating consisting of a metal matrix with integrated ceramic nanoparticles can be provided, which is realized by electrolytic or galvanic co-deposition from a colloid of an aqueous solution of metal salts and dispersed ceramic nanoparticles.

[0024] The ceramic is preferably selected from the group comprising aluminum oxide, zirconium oxide, silicon carbide, and / or silicon nitride. These ceramic materials are characterized by their high bioinert properties. Oxide ceramics such as aluminum oxide (Al 2 O 3 ), in particular, demonstrate high hemocompatibility and blood compatibility. Non-oxide ceramics such as silicon carbide (SiC) in its various polymorphic modifications also demonstrate excellent blood compatibility.

[0025] A metal matrix consisting of a combination of nickel, cobalt, chromium, molybdenum, and / or iron with incorporated ceramic particles, in particular aluminum oxide, is preferred. The combination of metals is preferably an alloy of nickel, cobalt, chromium, molybdenum, and / or iron. A preferred combination of metals are alloys such as nickel-cobalt-chromium alloys (NiCoCr), cobalt-chromium alloys, nickel-chromium alloys, or nickel-chromium-molybdenum-cobalt alloys. The metal used can correspond to the metal or metal alloys from which the metallic cardiovascular implant is formed. Another preferred combination of metals is a nickel-chromium-iron alloy (NiCrFe).

[0026] In preferred embodiments, the graded metal-ceramic composite coating is formed from aluminum oxide particles in a matrix of cobalt and nickel or chromium and cobalt, preferably in a matrix of cobalt, nickel, and chromium. A CoNi-Al 2 O 3 metal-ceramic composite coating exhibits particularly good flexibility and adhesion. Furthermore, it is possible to produce very thin layers.

[0027] Overall, a method and a graded metal-ceramic composite coating on a metallic cardiovascular implant can be provided, providing improved hemocompatibility and increased durability of the coated implants.

[0028] Unless otherwise specified, the technical and scientific terms used have the meaning commonly understood by one of ordinary skill in the art to which this invention belongs.

[0029] Examples to illustrate the present invention are given below.

[0030] The figures show: Figure 1 shows a cross-section of a hydrometallurgically nickel-coated vascular prosthesis. Figure 2 shows a scanning electron microscope image of the surface of a stainless steel substrate with a metal-ceramic composite coating of nickel and Al 2 O 3 populated with cells. Figure 3 shows a scanning electron microscope image of the surface of a graded metal-ceramic composite coating of nickel with aluminum oxide nanoparticles. Figure 4 shows a scanning electron microscope image of the surface of a graded metal-ceramic composite coating of a nickel-cobalt alloy with aluminum oxide nanoparticles. Example 1 Coating a vascular prosthesis with nickel

[0031] A commercial vascular prosthesis (Medtronic Integrity Coronary Stent System, 2.75 mm x 12 mm) was expanded through the balloon delivery system and separated from the delivery system. The stent was immersed in 1M HCl solution for 3 min for activation, then rinsed with double-distilled water and dried.

[0032] A nickel electrolyte was used as the electrolyte solution, which was prepared as follows: 240 g / L NiSO 4 *6H 2 O, 30 g / L NiCl 2 *6H 2 O, and 30 g / L H 3 BO 3 were dissolved in double-distilled water with constant stirring using a magnetic stirrer (300 rpm) at a temperature of 50°C. The pH of the electrolyte was adjusted to pH 4 with further addition of boric acid. The vascular prosthesis served as the cathode and pure nickel sheet as the anode with a 2 cm separation. Both electrodes were immersed in the electrolyte. The current was set to 0.1 A, and the plating time was 15 minutes at a temperature of 50°C. After electrolysis, the sample was removed from the electrolyte and cleaned with deionized water in an ultrasonic bath for 15 minutes, and then dried.

[0033] The Figure 1 shows a cross-section of the coated vascular prosthesis. How to Figure 1A thin layer of nickel was deposited that completely encloses the cardiovascular implant. Example 2

[0034] Deposition and cytotoxic investigation of a graded metal-ceramic composite coating of nickel and Al 2 O 3 on a stainless steel substrate 2.1 Deposition of a graded metal-ceramic composite coating of nickel and Al 2 O 3 on a stainless steel substrate

[0035] A 304L stainless steel substrate measuring 10 x 10 x 2 mm was immersed in a 1M HCl solution for 3 minutes for activation, then rinsed with double-distilled water and dried. Electrolyte solutions containing 240 g / L NiSO 4 *6H 2 O and 30 g / L NiCl 2 *6H 2 O were prepared as described in Example 1, with two samples additionally adding 15 g / L or 30 g / L of dispersed alumina nanoparticles (alumina nanopowder, 40-50 nm, Alfa Aesar). The substrate, in a sample holder, served as the cathode, and a pure nickel sheet as the anode at a distance of 2 cm. All substrates were coated with three layers each at duty cycles of 90% (first layer), 50% (second layer), and 10% (third layer) for 6 minutes each. The frequency was set to 100 Hz. Cleaning was performed in the same manner as described in Example 1. 2.2 Cytotoxic testing

[0036] For cytotoxic testing, the substrates prepared according to Example 2.1 were washed with 70% ethanol for 3 minutes after electrolysis and rinsed three times with phosphate-buffered saline (PBS). The substrates were then placed in 24-well plates.

[0037] Cytotoxicity tests were performed according to ISO 10993 / 5 using cells of the mouse fibroblast cell line L929 and human endothelial cells (Human Coronary Artery Endothelial Cells, HCAEC). Specifically, the medium from L929 and HCAEC cells was aspirated, and the cells were washed with PBS. 3 ml of trypsin-EDTA solution T 0.05 and 7 ml of medium were added. A portion of the cells was treated with CASY ®< ton, and the cells were counted. The remaining cells in the medium were centrifuged for 3 minutes at 220 g (9.81 m / s 2< ) for HCAEC cells and for 7 minutes at 1200 rpm for L929 cells. The medium was aspirated, the cells were resuspended in 1 ml of medium, and plasmocin was added. 10,000 cells were placed per square centimeter of the coated substrate. The samples were stored in an incubator for 24 hours.The cells were then stained with a staining solution containing 600 µl Ringer's solution, 5 ng / ml fluorescein acetate (FDA), and 5 ng / ml propidium iodide (PI7) and counted. Tables 1 and 2 below show the results of the cytotoxicity tests. Table 1: Results of cytotoxicity tests with L929 cells: Coating of the substrate Cell mortality nickel 8,7 % Nickel matrix with dispersed Al 2 O 3 (15 g / L) 2,87 % Nickel matrix with dispersed Al 2 O 3 (30 g / L) 2,15 % Table 2: Results of cytotoxicity tests with HCAEC cells: Coating of the substrate Cell mortality nickel 10,29 % Nickel matrix with dispersed Al 2 O 3 (15 g / L) 1,65 % Nickel matrix with dispersed Al 2 O 3 (30 g / L) 2,41 %

[0038] As can be seen from the results in Tables 1 and 2, increasing ceramic content showed a significantly positive effect on cell behavior. This demonstrates that cytocompatibility increases with increasing ceramic content.

[0039] The Figure 2shows a microscopic image (scanning electron microscope, Environmental Scanning Electron Microscope (ESEM XL30 FEG, FEI, Eindhoven, Netherlands)) of the surface of the stainless steel substrate coated with a nickel matrix containing dispersed Al 2 O 3 (30 g / L) colonized with HCAEC cells after 24 hours of incubation. Light microscopy images confirmed that after 24 hours of incubation, the cells on the substrates coated with higher aluminum oxide content appeared significantly more vital. Example 3 Deposition of a graded metal-ceramic composite coating of nickel and Al 2 O 3 on a stainless steel substrate

[0040] A 304L stainless steel substrate measuring 50x20x2 mm was cleaned in an ultrasonic bath for 30 min, immersed in a 1M HCl solution for 3 minutes for activation, and then rinsed with double-distilled water and dried. An electrolyte solution containing 240 g / L NiSO 4 *6H 2 O and 30 g / L NiCl 2 *6H 2 O was prepared as described in Example 1, with the addition of 100 g / L of dispersed alumina nanoparticles (alumina nanopowder, 40-50 nm, Alfa Aesar).

[0041] The substrate, in a sample holder, served as the cathode, and a pure nickel sheet as the anode, spaced 2 cm apart. The substrate was coated with three layers each at duty cycles of 90% (first layer), 50% (second layer), and 10% (third layer) at 100 Hz, and at a peak current of 0.3 A for 6 minutes per layer, for a total of 18 minutes. The coated substrate was cleaned in the same manner as described in Example 1.

[0042] The Figure 3 shows a scanning electron microscope image (Gemini SEM 500, ZEISS) of the surface of the coating with a metal matrix containing incorporated aluminum oxide nanoparticles. The image shows that aluminum oxide particles are incorporated into the metal matrix at the sample surface. These are visible as dark spots in the image. Example 4 Deposition of a graded metal-ceramic composite coating made of a nickel-cobalt alloy and Al 2 O 3 on a stainless steel substrate 4.1 Preliminary test: Coating a stainless steel substrate with a nickel-cobalt alloy

[0043] A 304L stainless steel substrate measuring 50x20x2 mm was cleaned in an ultrasonic bath for 30 min, immersed in 1M HCl solution for 3 minutes for activation, and then rinsed with double-distilled water and dried. The electrolyte was a nickel-cobalt electrolyte prepared as follows: 130 g / L CoSO 4 *7H 2 O, 130 g / L NiSO 4 *6H 2 O, and 30 g / L H 3 BO 3 were dissolved in double-distilled water at a temperature of 35°C while continuously stirring with a magnetic stirrer (150 rpm). The pH of the electrolyte was adjusted to pH 5 by adding NH 3 solution. The substrate, in a sample holder, served as the cathode, and a pure nickel sheet was used as the anode at a distance of 2 cm. The current was set to 0.2 A and the coating time was 12 minutes. Cleaning was carried out in the same way as described in Example 1.

[0044] By X-ray spectroscopy (EDX analysis) of the coated surface (Gemini SEM 500, ZEISS), it was determined that the applied NiCo alloy contained 86.3 wt% nickel and 13.5 wt% cobalt. 4.2 Deposition of a graded metal-ceramic composite coating made of a nickel-cobalt alloy and Al 2 O 3

[0045] A 304L stainless steel substrate measuring 50x20x2 mm was cleaned in an ultrasonic bath for 30 min, immersed in 1M HCl solution for 3 minutes for activation, and then rinsed with double-distilled water and dried. The electrolyte was a nickel-cobalt electrolyte prepared as follows: 130 g / L CoSO4 *7H2O, 130 g / L NiSO4 *6H2O, 30 g / L H3BO3, and 10 g / L Al2O3 were dissolved in double-distilled water at a temperature of 35°C while continuously stirring with a magnetic stirrer (150 rpm). The pH of the electrolyte was adjusted to pH 5 by adding NH3 solution. The substrate, in a sample holder, served as the cathode, and a pure nickel sheet as the anode at a distance of 2 cm. The current was set to 0.2 A and the coating time was 12 minutes. Cleaning was carried out in the same way as described in Example 1.

[0046] The Figure 4shows a scanning electron microscope image (Gemini SEM 500, ZEISS) of the surface (cross-section) of the coating with a nickel-cobalt matrix containing incorporated aluminum oxide nanoparticles. The image shows that aluminum oxide particles have been incorporated into the metal matrix at the sample surface. The aluminum oxide particles are visible as dark spots in the image. Example 5 Coating a stainless steel substrate with a nickel-cobalt-chromium alloy

[0047] A 304L substrate measuring 50x20x2 mm was cleaned in an ultrasonic bath for 30 min, immersed in a 1M HCl solution for 3 minutes, then rinsed with double-distilled water and dried. The electrolyte was a nickel-cobalt-chromium electrolyte with the following composition: 60 g / L CoSO 4 *7H 2 O, 60 g / L NiSO 4 *6H 2 O, 120 g / L CrCl 3 *6H 2 O, and 30 g / L H 3 BO 3 . The chemicals were dissolved with constant stirring at a temperature of approximately 65°C. The pH was adjusted to pH 2 with an NH 3 solution and boric acid. The substrate, in a sample holder, served as the cathode, and a pure nickel sheet as the anode at a distance of 2 cm. The current was set to 0.1 A, and the coating time was 30 minutes. Cleaning was carried out in the same manner as described in Example 1.

[0048] By X-ray spectroscopy (EDX analysis, Gemini SEM 500, ZEISS) of the coated surface, it was determined that the metal composition of the deposited NiCoCr alloy was 14.5 wt% nickel, 78.4 wt% cobalt and 1.4 wt% chromium.

Claims

1. Method for producing a graded metal-ceramic composite coating on a metallic cardiovascular implant, characterized in that the composite coating is applied via a hydrometallurgical method from an aqueous dispersion comprising dissolved metal salt or a dissolved metal compound and dispersed ceramic particles.

2. Method according to Claim 1, characterized in that the metal of the metal salt is selected from the group comprising nickel, cobalt, chromium, molybdenum, iron and combinations thereof.

3. Method according to Claim 1 or 2, characterized in that the concentration of the metal salt or salts or of the metal compound in the aqueous dispersion is in the range from ≥ 10 g / L to ≤ 500 g / L, preferably in the range from ≥ 10 g / L to ≤ 400 g / L, more preferably in the range from ≥ 30 g / L to ≤ 300 g / L.

4. Method according to any of the preceding claims, characterized in that the aqueous dispersion has a pH in the range from ≥ 2 to ≤ 7, more preferably in the range from ≥ 2 to ≤ 5.

5. Method according to any of the preceding claims, characterized in that the ceramic is selected from the group comprising aluminium oxide, zirconium oxide, silicon carbide and / or silicon nitride.

6. Method according to any of the preceding claims, characterized in that the ceramic particles have a mean particle size in the range from ≥ 30 nm to ≤ 100 nm, preferably in the range from ≥ 40 nm to ≤ 100 nm, more preferably in the range from ≥ 50 nm to ≤ 70 nm.

7. Metallic cardiovascular implant, the implant comprising a graded metal-ceramic composite coating of a metal selected from the group encompassing nickel, cobalt, chromium, molybdenum, iron and combinations thereof and particles of a ceramic selected from the group encompassing aluminium oxide, zirconium oxide, silicon carbide and / or silicon nitride, wherein the materials fraction of the metal decreases continuously from the surface of the metallic implant towards the outside in the graded metal-ceramic composite coating, while the fraction of ceramic particles increases in the opposite direction, produced by a method according to any of Claims 1 to 6.

8. Implant according to Claim 7, characterized in that the metallic cardiovascular implant is a stent.

9. Implant according to Claim 7 or 8, characterized in that the combination of the metals is an alloy formed of nickel, cobalt, chromium, molybdenum and / or iron.

10. Implant according to any of Claims 7 to 9, characterized in that the combination of the metals is an alloy selected from nickel-cobalt-chromium alloys, cobalt-chromium alloys, nickel-chromium alloys or nickel-chromium-molybdenum-cobalt alloys.

11. Implant according to any of Claims 7 to 10, characterized in that the combination of the metals is a nickel-chromium-iron alloy.

12. Implant according to any of Claims 7 to 11, characterized in that the graded metal-ceramic composite coating is formed of aluminium oxide particles in a matrix of cobalt and nickel or chromium and cobalt, preferably in a matrix of cobalt, nickel and chromium.